Peer Review History
| Original SubmissionJuly 17, 2020 |
|---|
|
PONE-D-20-22170 Implementation status of national tuberculosis infection control guidelines in Bangladeshi hospitals PLOS ONE Dear Dr. Nazneen, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please find the comments from three reviewers below. The reviewers have requested some more context and detail in the methodology, in order to ensure that the study is fully reproducible by another researcher. Please note that while the reviewers have suggested specific papers for the literature review, there is no requirement from the journal to include these specific papers. We would also recommend that you thoroughly copyedit your manuscript, as some grammatical errors remain. If you do not know anyone who can help you with this, you may consider working with a professional copyeditor. Please submit your revised manuscript by Dec 20 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Hanna Landenmark Associate Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service. Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (http://learn.aje.com/plos/) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website (www.editage.com) and enter referral code PLOSEDIT for a 15% discount off Editage services. If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free. Upon resubmission, please provide the following:
3. Under data analysis, the team reviewed the transcripts multiple times. Please specify how many times the team reviewed and if intercoder agreement was assessed. 4. Under study design, you indicate that the study utilized both qualitative and quantitative data - which were entered into MS excel for descriptive analysis. However, there are no text or tables summarizing quantitative findings. If there are no quantitative findings to report, please delete the methods section to show that only qualitative data were collected. 5. As part of your revision, please complete and submit a copy of the COREQ Guidelines checklist, a document that aims to improve experimental reporting and reproducibility of qualitative studies for purposes of post-publication data analysis and reproducibility: https://www.equator-network.org/reporting-guidelines/coreq/. Please include your completed checklist as a Supporting Information file. Note that if your paper is accepted for publication, this checklist will be published as part of your article 6. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: No Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: In this article the authors aimed to assess the implementation of the TB IPC healthcare measures in health settings, Bangladesh. This is an important and interesting study. They identified poor implementation of TB IPC measures in the study settings. In the ‘Discussion’ section, the authors cited other studies that found the same problems in implementation. However, it is important to cite studies that have been successful in implementing TB IPC guidelines and assess possible differences. For example, I suggest the authors to cite the study: Azeredo ACV et al. Tuberculosis in Health Care Workers and the Impact of Implementation of Hospital Infection-Control Measures. Workplace Health Saf 2020; doi:10.1177/2165079920919133. Reviewer #2: The tool and the data used for facility assessment survey and for the observation of TB infection prevention and control practices were not included. All other comments to the authors are in the review note. Reviewer #3: Thank you to the authors for this important work. Please see my comments below. Introduction Provide statistics to illustrate the incidence of PTB and MDR TB in Bangladesh. How is TB managed in the country? The study focuses on hospitalisation TB patients. Are all TB patients hospitalised, or are they treated in the community? Where are patients diagnosed – at clinics, hospitals? It would be useful for the reader to have a better understanding of how the TB program works in Bangladesh. Are the National Tuberculosis Control Program TB IPC guidelines based on the 2009 WHO Policy on TB Infection Control in Health-Care Facilities, Congregate Settings and Households? This should be clarified so that the reader has a better context of the Bangladesh guidelines (in the reference list there is no website indicated for the reader to see what appears in these guidelines). Consider removing “well-known” information from the introduction. For example, how PTB is spread. Material and method The study sites should be explained in more detail. Why the inclusion of TB specialist hospitals and tertiary care hospitals. What are their different functions? It appears as if one of the hospitals was a non-government hospital. Please explain. The nature of the hospitals may influence the responses regarding the implementation of IPC. Did you interview TB managers from the Ministry of Health? It would be interesting to hear their perspectives on the implementation of the national TB infection control guidelines. This appears to be a mixed methods study – qualitative interview and quantitative observations? Please explain the type of interviews conducted. Were they semi-structured interviews? It should be clear that the facility assessment tool was an observation checklist. Over what period of time were the observations conducted (e.g. when triage, cough etiquette and patients wearing a surgical masks were observed was it once off, for a day, etc.). Where in the hospital did you look if there were posters on IPC? In the tertiary hospitals, were did you observe UVGI? Describe the interview guide and assessment tool in more detail. Was it based on the national TB infection control guidelines? This is important to know as you were assessing the implementation of the guidelines. Consider including a table that explains the different controls that should be implemented according to the National TB infection control guidelines. It appears as if the qualitative data was analysed thematically? Please mention this under the data analysis section. Include the Ethics Clearance number. Did you need to obtain permission from the Ministry of Health to undertake this study? Results Were all participants working directly with TB patients? Describe the role of the project director. It would be useful to indicate separately what the laboratory personnel did to ensure TB IPC. Their roles are somewhat different from that of nurses and doctors working directly with TB patients. It would be useful at the start of each section to have an introductory sentence to explain the information that will follow. For example: In terms of managerial controls we looked at the availability of TB infection control committees and facility specific IPC plans. Table 1 is confusing. It is not clear if the activities listed were all in place? Consider deleting this table. As no one appeared to be aware of the National TB infection control guidelines, did you follow this up at a higher level? For example, with a TB manager at national level? Why is “Operational Research” a new heading? Does it fall under “managerial controls”? Why is the risk allowance discussed under administrative controls? Please explain line 187-188: There was no prevention or healthcare package available for HCWs in the study hospitals. Explain how the hospitals lacked space to put up signs for restricted areas. How did the pathologists ensure cough etiquette during sputum collection? Was this done in a separate room, outside? Do the pathologists collect sputum? Do nurses and doctors also do this? Natural ventilation is mentioned under administrative controls. This should be moved to the section on environmental controls. There appears to be some overlap in the sections on managerial and administrative controls, particularly with regard to workplace policies/plans and notification/surveillance of HCWs with TB. Line 244-246: The observation relating to N95 respirators in the tertiary care hospital – clarify if this observation was done in a TB ward. Include more direct quotes from the interviews. Discussion Keep the first paragraph more general. Save the recommendations for later in the discussion. Line 294: The third vital step… Step 1 and 2 are not specifically indicated, so it is confusing to see a third step. Line 310-312: It is not a limitation of the study that key informants were not aware of the national guidelines (unless you interviewed the wrong key informants). This is acually an important finding. It would have been useful to follow-up on this with the relevant mangers at national level, to see why the guidelines have not been rolled out. The main recommendations should be to ensure that the guidelines are rolled out to all facilities and HCWs should be trained on these guidelines. References Check for accuracy and completeness. For example: Reference 3 – the actual website is missing. Sometimes days, months and years are provided while in other instances only the year is provided. The manuscript should be professionally language edited. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
PONE-D-20-22170R1 Implementation status of national tuberculosis infection control guidelines in Bangladeshi hospitals PLOS ONE Dear Dr. Nazneen, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses this point raised during the review process. While your study is largely qualitative, the observation checklist completed at 11 facilities constitutes a quantitative component. Please consider revising this under the methods section. Please submit your revised manuscript by 26 March 2021. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Michelle Engelbrecht, PhD. Academic Editor PLOS ONE Additional Editor Comments (if provided): Thank you for addressing the reviewers' comments so thoroughly. The article reads well. Just one additional comment, while your study was mainly qualitative, it did contain a quantitative component, namely the observation checklist that was completed at 11 hospitals. Consider revising accordingly in the methods section. [Note: HTML markup is below. Please do not edit.] [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Implementation status of national tuberculosis infection control guidelines in Bangladeshi hospitals PONE-D-20-22170R2 Dear Dr. Nazeen We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Michelle Engelbrecht, PhD. Guest Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-20-22170R2 Implementation status of national tuberculosis infection control guidelines in Bangladeshi hospitals Dear Dr. Nazneen: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Michelle Engelbrecht Guest Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .